Literature DB >> 17918299

Endocrine paraneoplastic syndromes in small cell lung carcinoma. Two case reports.

D Radulescu1, S Pripon, D Bunea, T E Ciuleanu, L I Radulescu.   

Abstract

Paraneoplastic syndromes are frequently detected in many small cell lung cancer (SCLC) patients. In the present paper we report 2 cases of patients diagnosed with SCLC, in whom 2 distinct endocrine paraneoplastic syndromes were identified during diagnosis. In the first patient, severe hyponatremia and renal sodium loss with inappropriate antidiuresis was found during routine laboratory tests. Serum antidiuretic hormone (ADH) level was within normal limits, but the atrial natriuretic peptide (ANP) level was elevated. The second case presented with severe hypercalcemia secondary to an excessive parathormone (PTH) secretion. We discuss the 2 cases and review the literature.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17918299

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  3 in total

Review 1.  Paraneoplastic syndromes associated with lung cancer.

Authors:  Nobuhiro Kanaji; Naoki Watanabe; Nobuyuki Kita; Shuji Bandoh; Akira Tadokoro; Tomoya Ishii; Hiroaki Dobashi; Takuya Matsunaga
Journal:  World J Clin Oncol       Date:  2014-08-10

2.  Small Cell Lung Cancer (SCLC) Presenting as Acute Pancreatitis: The Role of Hypercalcemia.

Authors:  Jessica Tan; Alejandro Calvo
Journal:  World J Oncol       Date:  2012-02-19

3.  Loss of the transcriptional repressor PAG-3/Gfi-1 results in enhanced neurosecretion that is dependent on the dense-core vesicle membrane protein IDA-1/IA-2.

Authors:  Tao Cai; Hiroki Hirai; Tetsunari Fukushige; Ping Yu; Guofeng Zhang; Abner L Notkins; Michael Krause
Journal:  PLoS Genet       Date:  2009-04-03       Impact factor: 5.917

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.